We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DELL:NYSEDell Technologies Inc. Analysis

Data as of 2026-03-10 - not real-time

$146.51

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Dell Technologies trades at $146.51, well above its 20‑day SMA (≈$129.64) but still below the 200‑day SMA (≈$129.92), indicating a neutral long‑term trend. Momentum indicators are bullish – the MACD histogram is positive and the signal line is bullish, while the RSI sits at 65, suggesting the stock is approaching over‑bought territory. Technical support sits near $111 and resistance near $154, giving the price room to test the upper band on the upside. Fundamentally, the company shows strong revenue growth (≈40%), a healthy operating cash flow, and a dividend yield of 1.72% with a modest payout ratio. The DCF model values Dell at roughly $414, implying a massive valuation gap, and analysts collectively rate the stock as a “Buy” with a median price target of $167, reflecting an upside of about 13% from current levels. Recent news highlights Dell’s push into edge AI with the PowerEdge XR9700 server and several analyst upgrades citing AI server momentum, reinforcing the growth narrative.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but RSI nearing over‑bought levels
  • Price approaching short‑term resistance around $154
  • Increasing volume supporting current price stability

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • AI‑focused product launches expanding higher‑margin revenue
  • Analyst upgrades and overweight ratings reflecting confidence
  • Undervaluation relative to DCF fair value and industry PE multiples

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term valuation gap (DCF fair value ~ $414 vs current price)
  • Sustained cash generation and dividend support
  • Strategic positioning in edge AI and enterprise infrastructure

Key Metrics & Analysis

Financial Health

Revenue Growth39.50%
Profit Margin5.23%
P/E Ratio16.9
ROA5.63%
P/B Ratio-39.6
Op. Cash Flow$11.2B
Free Cash Flow$-1360625024
Industry P/E36.8

Technical Analysis

TrendNeutral
RSI65.3
Support$111.20
Resistance$153.72
MA 20$129.64
MA 50$123.96
MA 200$129.92
MACDBullish
VolumeIncreasing
Fear & Greed Index76.14

Valuation

Fair Value$414.25
Target Price$165.48
Upside/Downside12.95%
GradeUndervalued
TypeGrowth
Dividend Yield1.72%

Risk Assessment

Beta1.81
Volatility77.41%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.